Respiratory Issues in patients with Spinal Muscular Atrophy (SMA) type 1, Treated with Disease-Modifying Therapy

M. Gaboli (Sevilla, Spain), M. López-Lobato (Sevilla, Spain), M. Madruga-Garrido (Sevilla, Spain), M. Borrero-Rodriguez (Sevilla, Spain), A. Palomo-Pavón (Sevilla, Spain), R. Escudero-Ávila (Sevilla, Spain)

Source: Virtual Congress 2021 – Primary ciliary dyskinesia and tracheostomy
Session: Primary ciliary dyskinesia and tracheostomy
Session type: E-poster
Number: 3470

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gaboli (Sevilla, Spain), M. López-Lobato (Sevilla, Spain), M. Madruga-Garrido (Sevilla, Spain), M. Borrero-Rodriguez (Sevilla, Spain), A. Palomo-Pavón (Sevilla, Spain), R. Escudero-Ávila (Sevilla, Spain). Respiratory Issues in patients with Spinal Muscular Atrophy (SMA) type 1, Treated with Disease-Modifying Therapy. 3470

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nusinersen for Spinal Muscular Atrophy type 1: Real-World Respiratory Experience
Source: Virtual Congress 2020 – Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects
Year: 2020

Respiratory and Motor Phenotypes and Correlations with Diaphragm Function in Patients with Late-Onset Pompe Disease (LOPD)
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018

Respiratory Muscle Strength in Stroke Patients and Healthy Controls: A Case Control Study
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018


Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019


Evaluation of Respiratory Muscle Strength and Balance in Berardinelli-Seip Congenital Lipodystrophy (BSCL) Patients from Brazil
Source: International Congress 2018 – Respiratory physiology and measurements
Year: 2018


Prevalence of Late-Onset Pompe Disease in Portuguese Patients with Diaphragmatic Paralysis: The DIPPER Study
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018

Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS)
Source: Virtual Congress 2021 – Imaging
Year: 2021



Responses to Two Different High-Intensity Interval Exercise Training Protocols on Pulmonary Function and Respiratory Muscle Strength In Diabetes Mellitus
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to  Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Respiratory Muscle Endurance, Peripheral Muscle Strength and Walking Parameters in Adult Cystic Fibrosis Patients
Source: Virtual Congress 2020 – A knowledge update on respiratory muscle function, assessment and training
Year: 2020


O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Resistance Training Alone Improves Lung Inflammation and Respiratory Muscle Strenght but not Lung Function and Mechanics in Mid-Age Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Case presentation: Spontaneous Pneumothorax in a Patient with Duchenne Muscular Dystrophy on Non-Invasive Ventilation
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Type 2 Diabetes Acentuates the Impairment in the Lung Function and Mechanics in Elderly
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020


Increased Osteoporosis and Hospitalization in Non-Cystic Fibrosis Bronchiectasis (NCFBr) Adults with Desaturation during 6 Minute Walk Test: a Five-year Study
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017